医疗保健从业者和其他专业人员对加巴类药物滥用和依赖的看法:定性研究的系统审查
Amy G McNeilage1,2, Evan Browne3, Suzanne Nielsen2
1Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
European journal of pain (London, England)
|September 2, 2025
概括
医疗保健专业人员报告说,由于社会和结构因素导致的 gabapentinoid 滥用存在重大挑战. 需要基于证据的系统策略来减少滥用这些药物的危害并改善患者的护理.
科学领域:
- 药理学与公共卫生
- 质量研究综合
- 药物成
背景情况:
- 全球加巴类药物治疗慢性疼痛的处方增加.
- 人们越来越担心 gabapentinoid 的滥用和依赖.
- 需要了解这些挑战的专业观点.
研究的目的:
- 综合医疗保健和其他专业人士对 gabapentinoid 滥用和依赖的观点.
- 从专业的角度来看,识别 gabapentinoid 滥用的驱动因素和迹象.
- 探索拟议的减少危害的策略.
主要方法:
- 对19项研究进行了定性系统审查.
- 在六个主要数据库中搜索到2025年5月.
- 主题综合和GRADE-CERQual进行信心评估.
主要成果:
- 大多数研究来源于物质使用和执法环境.
- 滥用药物的驱动因素包括多种药物使用,阿片类药物替代,痛苦和缺乏非药物治疗.
- 专业人士发现了伦理紧张局势,并提出了教育和政策改革等减少危害的策略.
结论:
- 滥用 gabapentinoid 受到临床,社会和结构因素的影响.
- 系统性反应至关重要,不仅限于个人处方者.
- 吸取阿片类药物政策的教训应该为平衡,富有同情心和以证据为基础的战略提供指导.
相关概念视频
Drug Abuse and Addiction: Pharmacological Phenomena
655
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
655
Drug Dependence
1.2K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.2K
Analgesia and Pain Management
788
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
788
CNS Depressants: Barbiturates and Benzodiazepines
466
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
466
Antiepileptic Drugs: GABAergic Pathway Potentiators
635
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
635
Antiepileptic Drugs: Potassium Channel Activators
274
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
274


